molt-3

TJ191 是一种选择性抗癌试剂，靶向低 TβRIII 表达的恶性T 细胞白血病 淋巴瘤细胞，可研究癌症。

Tamarixetin (4'-O-Methyl Quercetin) 是一种槲皮素的天然类黄酮衍生物，具有抗氧化、抗炎作用，能够防止心肌肥厚。

Puromycin dihydrochloride (CL13900 dihydrochloride) 属于肉桂酰胺腺苷抗生素，是一种蛋白质合成的抑制剂。Puromycin dihydrochloride 通过与 RNA 结合来抑制蛋白质合成，具有抗肿瘤和抗锥虫活性。

Panobinostat (NVP-LBH589) 是一种广谱的 HDAC 抑制剂 (IC50=5 nM)，具有口服活性和非选择性。Panobinostat 具有抗肿瘤活性，可以诱导细胞凋亡和自噬。

Selinexor (KPT-330) 是一种 CRM1 的小分子抑制剂，具有选择性和口服活性。Selinexor 可以阻滞细胞周期、诱导细胞凋亡，具有抗肿瘤活性，可以用于治疗多发性骨髓瘤。

BCL-XL-IN-3 (Compound 11) 是一种 BCL-XL 的抑制剂，Ki 小于 0.01 nM。它能够抑制正常 Molt-4 细胞和经 Digitonin 透化处理的 Molt-4 细胞的活力，EC50 值分别为 77.8 nM 和 0.07 nM。BCL-XL-IN-3 被用作 ADC 毒素以合成 Clezutoclax。

Nornidulin is a depsidone originally isolated from A. nidulans that has antibacterial activity against M. tuberculosis and M. ranoe as well as antifungal activity against T. tonsurans and M. audouini. It also inhibits the growth of methicillin-resistant S. aureus (MRSA; MIC = 2 μg ml) and has larvicidal activity toward Artemia (LC50 = 1.7 μg ml). Nornidulin has cytotoxic activity in MOLT-3 cells (IC50 = 35.7 μM) but not HuCCA-1, HepG2, or A549 cells (IC50s = >116.4 μM).

KZR-616, a first-in-class inhibitor of the immunoproteasome, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP7/mLMP7) subunits of the immunoproteasome. KZR-616 has the potential for the research of multiple autoimmune diseases[1][2]. KZR-616 also inhibits MECL-1 subunit (IC50=623 nM) and constitutive proteasome β5 subunit (IC50=688 nM). KZR-616 maintains LMP7 and LMP2 selective inhibition in MOLT-4 cells. KZR-616 (250 nM) shows a comparable cytokine inhibition profile peripheral blood mononuclear cells (PBMC)[1].KZR-616 is an immunoproteasome-selective inhibitor identified based on the optimization of ONX-0914 and PR-924 [3]. KZR-616 (5 mg/kg; i.v.; dosing was repeated on days 6, 8, 11, and 13) shows efficacy in the anticollagen antibody induced arthritis (CAIA) model[1]. [1]. Johnson HWB, et al. Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide). J Med Chem. 2018 Dec 27;61(24):11127-11143. [2]. Muchamuel T, et al. FRI0296 Kzr-616, a selective inhibitor of the immunoproteasome, blocks the disease progression in multiple models of systemic lupus erythematosus (SLE). Annals of the Rheumatic Diseases 2018;77:685. [3]. Xi J, et al. Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases. Eur J Med Chem. 2019;182:111646.

Nidulin is a depsidone originally isolated from A. nidulans. It is active against the bacteria M. tuberculosis and M. ranoe, as well as the fungi T. tonsurans and M. audouini. It also inhibits the growth of methicillin-resistant S. aureus (MRSA; MIC = 4 μg ml) and has larvicidal activity toward Artemia (LC50 = 2.8 μg ml). Nidulin is cytotoxic to MOLT-3 cells (IC50 = 21.2 μM) but not HuCCA-1, HepG2, or A549 cells (IC50s = >112.7 μM). It inhibits aromatase with an IC50 value of 11.2 μM.

6β,7β-Epoxyasteriscunolide A 是一种具有细胞毒性的倍半萜类化合物，其对 HL-60 和 MOLT-3 白血病细胞系展现出的 IC50 值介于 4.1-5.4 μM 之间。

Cyclopentenylcytosine（CPC）是一种核苷类似物，通过抑制CTP合成酶来降低白血病细胞中的胞苷三磷酸（CTP）和脱氧胞苷三磷酸（dCTP）水平。此外，Cyclopentenylcytosine 促进 1-β-D-阿拉伯核糖甘露苷胞苷(araC)的磷酸化并增加其插入DNA的活性。Cyclopentenylcytosine 以浓度（50-300 nM）和时间依赖（8-16小时）的方式诱导人T淋巴细胞系MOLT-3的凋亡和坏死。Cyclopentenylcytosine与araC联合使用可以增强对凋亡和坏死的诱导作用及其在T淋巴母细胞中的细胞毒性。

Myriceric acid B is a potent HIV-1 entry inhibitor targeting gp41 and can serve as a lead compound for novel anti-HIV-1 drug development. It scavenges DPPH free radicals with an IC50 value of 21.8 µM and inhibits aromatase activity with an IC50 value of [incomplete data].